NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
(NASDAQ: ELAB) Delayed: 4.42 -0.36 (7.53%)
Previous Close $4.78    52 Week High $ 
Open $4.68    52 Week Low $ 
Day High $4.74    P/E N/A 
Day Low $4.35    EPS $ 
Volume 21,694